10-Q Filing

BENITEC BIOPHARMA INC. CIK: 1808898 Q1 2024

Filing Information

Form Type	10-Q
Accession Number	`0001193125-23-275377`
Period End Date	20230930
Filing Date	20231113
Fiscal Year	2024
Fiscal Period	Q1
XBRL Instance	d576860d10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 38 Cash Flow Statement 39 Stockholders Equity 18

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	160.00M	shares	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	160.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	2.55M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.48M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	1.67M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.86M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	1.67M	shares	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$13.00K	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	2.55M	shares	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$13.00K	USD	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$55.00K	USD	Point-in-time
Trade and other receivables	`AccountsAndOtherReceivablesNetCurrent`	$53.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$482.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.73M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$26.41M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$87.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$68.00K	USD	Point-in-time
Deposits	`DepositAssets`	$25.00K	USD	Point-in-time
Deposits	`DepositAssets`	$25.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	$85.00K	USD	Point-in-time
Prepaid and other assets	`PrepaidExpenseAndOtherAssetsNoncurrent`	$97.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$463.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$526.00K	USD	Point-in-time
Total assets	`Assets`	$4.46M	USD	Point-in-time
Total assets	`Assets`	$27.05M	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.79M	USD	Point-in-time
Trade and other payables	`AccountsPayableAndOtherAccruedLiabilitiesCurrent`	$3.23M	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$460.00K	USD	Point-in-time
Accrued employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$472.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$275.00K	USD	Point-in-time
Lease liabilities, current portion	`OperatingLeaseLiabilityCurrent`	$280.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.98M	USD	Point-in-time
Lease liabilities, less current portion	`OperatingLeaseLiabilityNoncurrent`	$211.00K	USD	Point-in-time
Lease liabilities, less current portion	`OperatingLeaseLiabilityNoncurrent`	$284.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$4.75M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.26M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.0001 par value-160,000,000 shares authorized; 2,547,434 shares and 1,645,951 shares issued and outstanding at September 30, 2023 and June 30, 2023, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value-160,000,000 shares authorized; 2,547,434 shares and 1,645,951 shares issued and outstanding at September 30, 2023 and June 30, 2023, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$168.92M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$196.93M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-173.84M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-167.89M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-830.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-780.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$22.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$202.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$2.88M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$4.46M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$27.05M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`Revenues`	-	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Royalties and license fees	`RoyaltiesAndLicenseFees`	$-106.00K	USD	1 Quarter
Royalties and license fees	`RoyaltiesAndLicenseFees`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.66M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.43M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.92M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.55M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$4.58M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$5.87M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.87M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.58M	USD	1 Quarter
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-56.00K	USD	1 Quarter
Foreign currency transaction loss	`ForeignCurrencyTransactionGainLossBeforeTax`	$-507.00K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-6.00K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-9.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-18.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Unrealized gain on investment	`UnrealizedGainLossOnInvestments`	$3.00K	USD	1 Quarter
Unrealized gain on investment	`UnrealizedGainLossOnInvestments`	-	USD	1 Quarter
Total other loss, net	`NonoperatingIncomeExpense`	$-513.00K	USD	1 Quarter
Total other loss, net	`NonoperatingIncomeExpense`	$-80.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.95M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Unrealized foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$50.00K	USD	1 Quarter
Unrealized foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$507.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$507.00K	USD	1 Quarter
Total other comprehensive income	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$50.00K	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-5.90M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-4.59M	USD	1 Quarter
Net loss per share: basic	`EarningsPerShareBasic`	$-2.76	USD	1 Quarter
Net loss per share: basic	`EarningsPerShareBasic`	$-7.98	USD	1 Quarter
Net loss per share: diluted	`EarningsPerShareDiluted`	$-2.76	USD	1 Quarter
Net loss per share: diluted	`EarningsPerShareDiluted`	$-7.98	USD	1 Quarter
Weighted average number of shares outstanding: basic	`WeightedAverageNumberOfSharesOutstandingBasic`	2.16M	shares	1 Quarter
Weighted average number of shares outstanding: basic	`WeightedAverageNumberOfSharesOutstandingBasic`	638,572.00	shares	1 Quarter
Weighted average number of shares outstanding: diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	638,572.00	shares	1 Quarter
Weighted average number of shares outstanding: diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	2.16M	shares	1 Quarter

Cash Flow Statement 39 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.95M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$19.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$42.00K	USD	1 Quarter
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$63.00K	USD	1 Quarter
Amortization of right-of-use assets	`AmortizationOfRightOfUseAssets`	$60.00K	USD	1 Quarter
Unrealized gain on investment	`UnrealizedGainLossOnInvestment`	$3.00K	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$91.00K	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$302.00K	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-709.00K	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-220.00K	USD	1 Quarter
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$500.00K	USD	1 Quarter
Trade and other payables	`IncreasedecreaseInAccountsAndOtherPayables`	$566.00K	USD	1 Quarter
Accrued employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-11.00K	USD	1 Quarter
Accrued employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-4.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInLeaseLiabilities`	$-67.00K	USD	1 Quarter
Lease liabilities	`IncreaseDecreaseInLeaseLiabilities`	$-62.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.04M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.58M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Proceeds from issuance of common stock, pre-funded warrants, and common warrants	`ProceedsFromIssuanceOfCommonStockPreFundedWarrantsAndCommonWarrants`	$30.88M	USD	1 Quarter
Proceeds from issuance of common stock, pre-funded warrants, and common warrants	`ProceedsFromIssuanceOfCommonStockPreFundedWarrantsAndCommonWarrants`	$17.88M	USD	1 Quarter
Stock issuance costs	`PaymentsOfStockIssuanceCosts`	$1.87M	USD	1 Quarter
Stock issuance costs	`PaymentsOfStockIssuanceCosts`	$2.96M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$16.02M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.92M	USD	1 Quarter
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$501.00K	USD	1 Quarter
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$45.00K	USD	1 Quarter
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$12.47M	USD	1 Quarter
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$23.39M	USD	1 Quarter
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.55M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.88M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.08M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.49M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.55M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$25.88M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.08M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.49M	USD	Point-in-time

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Payments For Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$1.87M	USD	1 Quarter
Payments For Stock Issuance Costs	`PaymentsOfStockIssuanceCosts`	$2.96M	USD	1 Quarter
Balance at the beginning	`StockholdersEquity`	$22.31M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$14.61M	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$202.00K	USD	Point-in-time
Balance at the beginning	`StockholdersEquity`	$2.88M	USD	Point-in-time
Issuance of common stock, pre-funded warrants, and common Warrants sold for cash, net of offering costs	`IssuanceAndExerciseOfPrefundedAndCommonWarrantsNetOfTransactionCosts`	$16.02M	USD	1 Quarter
Issuance of common stock, pre-funded warrants, and common Warrants sold for cash, net of offering costs	`IssuanceAndExerciseOfPrefundedAndCommonWarrantsNetOfTransactionCosts`	$27.92M	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$91.00K	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$302.00K	USD	1 Quarter
Foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$50.00K	USD	1 Quarter
Foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$507.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.95M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.09M	USD	1 Quarter
Balance at end	`StockholdersEquity`	$22.31M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$14.61M	USD	Point-in-time
Balance at end	`StockholdersEquity`	$202.00K	USD	Point-in-time
Balance at end	`StockholdersEquity`	$2.88M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.